-
Pharmacists Ready to Receive and Administer COVID-19 Vaccines, According to APhA Survey
prnewswire
December 03, 2020
More than three quarters of pharmacists plan to be vaccinated with one of the COVID vaccines, and 60% will be set up and ready to vaccinate patients as soon as the vaccine is available, in a recent nationwide survey of 400 pharmacists conducted by the ...
-
Expect to commercialise vaccine facility by April-May 2021: Aurobindo Pharma
expresspharma
December 01, 2020
It is investing around Rs 275 crores on the facility to produce vaccines for the treatment of various viral diseases including COVID-19.
-
Moderna announces vaccine efficacy of 94.1 per cent, to file for EUA with US FDA
expresspharma
December 01, 2020
Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe.
-
Russia to vaccinate armed forces against COVID-19 as new cases hit daily record
expresspharma
November 30, 2020
Russia plans to vaccinate more than 400,000 military personnel against COVID-19, Defence Minister Sergei Shoigu said on Friday, as authorities reported a record 27,543 new coronavirus cases.
-
The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets
prnasia
November 26, 2020
The Russian Direct Investment Fund announces the cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, which is less than $20 for the two doses necessary to vaccinate one person.
-
Governments should work as a team for smooth, sustained COVID-19 vaccination drive: PM Modi
expresspharma
November 25, 2020
The PM said that any vaccine against coronavirus that is administered to citizens will meet all necessary scientific criteria.
-
Vaccine is 94.5 per cent effective in preventing COVID-19: Moderna
expresspharma
November 17, 2020
Moderna said its experimental vaccine was 94.5 per cent effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second US company to report results that far exceed expectations.
-
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate
prnasia
November 16, 2020
Cytiva, a global life sciences leader, is supporting Clover Biopharmaceuticals, a global clinical-stage biotechnology company, to help accelerate the development and manufacturing of a protein-based S-Trimer subunit vaccine candidate.
-
Novavax Expands Facility to Support Global Vaccine Development
contractpharma
November 11, 2020
Expands campus with two properties to support vaccine research and development, manufacturing, business operations.
-
Drug developers are interested in innovative polymers and multilayer technology to help meet packaging requirements
expresspharma
November 11, 2020
Rajarshi Datta, Country Head & General Manager – South Asia, Honeywell Advanced Materials informs there is a growing need for new packaging technologies that allow the pharma industry to launch drugs to market faster while reducing operational costs and..